Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D J Webb

Showing results (81-90 of 360) with videos related to

Pageof 36
Sort By:
Trends in Pharmacological Sciences|March 25, 2000
Endothelins are potent vasoconstrictors, and much more besidesG A Gray, B Battistini, D J Webb
Clinical Science (London, England : 1979)|October 1, 1988
Angiotensin II augments sympathetically induced venoconstriction in manN Benjamin, J G Collier, D J Webb
Age and Ageing|March 20, 1998
The Trevor Howell Lecture. Age, arterial stiffness and the endotheliumJ R Cockcroft, I B Wilkinson, D J Webb
Lancet (London, England)|January 6, 2000
Aortic pulse-wave velocityI B Wilkinson, D J Webb, J R Cockcroft
QJM : Monthly Journal of the Association of Physicians|November 15, 2000
Uric acid as a risk factor for cardiovascular diseaseW S Waring, D J Webb, S R Maxwell
Clinical Science (London, England : 1979)|April 1, 1990
Bradykinin has no acute effect on the response of forearm blood flow to sympathetic stimulation in manM J Cullen, J R Cockcroft, D J Webb
British Journal of Clinical Pharmacology|June 26, 1999
Clinical pharmacology and therapeutics in a changing worldD N Bateman, G T McInnes, D J Webb
Circulation|August 1, 1995
Endothelin ETA and ETB receptors cause vasoconstriction of human resistance and capacitance vessels in vivoW G Haynes, F E Strachan, D J Webb
Trends in Pharmacological Sciences|June 1, 1993
Endothelin: progress in pharmacology and physiologyW G Haynes, A P Davenport, D J Webb
Journal of Cardiovascular Pharmacology|January 1, 1995
Physiologic role of endothelin in maintenance of vascular tone in humansW G Haynes, C E Ferro, D J Webb
Pageof 36

Showing results (81-90 of 360) with videos related to

Sort By:
Pageof 36
Trends in Pharmacological Sciences|March 25, 2000
Endothelins are potent vasoconstrictors, and much more besidesG A Gray, B Battistini, D J Webb
Clinical Science (London, England : 1979)|October 1, 1988
Angiotensin II augments sympathetically induced venoconstriction in manN Benjamin, J G Collier, D J Webb
Age and Ageing|March 20, 1998
The Trevor Howell Lecture. Age, arterial stiffness and the endotheliumJ R Cockcroft, I B Wilkinson, D J Webb
Lancet (London, England)|January 6, 2000
Aortic pulse-wave velocityI B Wilkinson, D J Webb, J R Cockcroft
QJM : Monthly Journal of the Association of Physicians|November 15, 2000
Uric acid as a risk factor for cardiovascular diseaseW S Waring, D J Webb, S R Maxwell
Clinical Science (London, England : 1979)|April 1, 1990
Bradykinin has no acute effect on the response of forearm blood flow to sympathetic stimulation in manM J Cullen, J R Cockcroft, D J Webb
British Journal of Clinical Pharmacology|June 26, 1999
Clinical pharmacology and therapeutics in a changing worldD N Bateman, G T McInnes, D J Webb
Circulation|August 1, 1995
Endothelin ETA and ETB receptors cause vasoconstriction of human resistance and capacitance vessels in vivoW G Haynes, F E Strachan, D J Webb
Trends in Pharmacological Sciences|June 1, 1993
Endothelin: progress in pharmacology and physiologyW G Haynes, A P Davenport, D J Webb
Journal of Cardiovascular Pharmacology|January 1, 1995
Physiologic role of endothelin in maintenance of vascular tone in humansW G Haynes, C E Ferro, D J Webb
Pageof 36